US Rare Earth Minerals to Acquire Bioxytran
Prior to the purchase, US Rare Earth Minerals, was formerly engaged in the sales and distribution of products derived from...
Abattis Signs Regulatory Services Agreement
Abattis Bioceuticals signed a letter of intent with dicentra for a suite of services to support Abattis's current and future...
Tetra Bio-Pharma Shares Reaction to Canadian Strategy for Legal Cannabis
Tetra Bio-Pharma shared their support for the Canadian government's proposal for the regulation of cannabis once it becomes legal for...
Abattis Announces Receipt of Cultivation License by LP Partner
Abattis Bioceuticals and its majority-owned testing and laboratory subsidiary, Northern Vine Canada announced their LP investment partner, Experion Biotechnologies received...
BioAmber Will Start Trading on the TSX
BioAmber announced it will begin trading on the TSX under the symbol BIOA starting May 3, 2017.
Propanc Gives Update on PRP Study
Propanc Biopharma provided an update on the development of the GMP-compliant investigational medicinal product (IMP) manufacture of PRP for First-In-Human...
AntriaBio Looks for Prosciento to Conduct Phase I Clinical Trial
AntriaBio began engaging Prosciento to conduct a clinical study of AB101 for patients with diabetes mellitus.